Eurofarma
Erica Teles de Menezes serves as the Head of Corporate Venture Capital at Eurofarma since September 2021, where responsibilities include managing Neuron Ventures Portfolio, implementing strategic innovation committees, and fostering partnerships with the M&A team. Prior to Eurofarma, Erica held several roles at L'Oréal from March 2017 to October 2021, including Sr. Open Innovation & Digital Manager and PL Marketing Product Manager, focusing on open innovation and product marketing. Earlier experience includes marketing positions at Mondelēz International from January 2012 to March 2017, where responsibilities spanned brand positioning strategy and product development. Erica began their career as a Junior Buyer at Brose and completed a Master of Science in Digital Innovation & Entrepreneurial Leadership at ESCP Business School in 2020, along with a Bachelor of Arts in Business Administration from Fachhochschule Münster.
This person is not in any teams
Eurofarma
5 followers
Since its establishment in 1972, Eurofarma has been operating in the health industry, producing and marketing products and services to improve people's quality of life. Focused on generating shared value, it operates in the areas of Prescription, Nos-Prescription, Generics, Hospital and Oncology. It offers over 700 products, over 2,000 SKUs and serves 42 medical specialties. In Brazil, it covers 100 therapeutic classes, which represent 70% of prescriptions in the entire market. Operating in 20 countries, with manufacturing facilities in Brazil and industrial parks in six other Latin American countries, it generated net sales of R$ 7.1 billion in 2021, a growth of 23% compared to the previous year, and employs more than 8,100 people.